Taking altogether, and considering the potential application of TI-based approaches to fight pathologies such as allergy (188), cancer (160) or autoimmune diseases (189), a deep understanding of Dectin-1-driven molecular events ignited by different ligands, and their relationship with TI, represents a research field of great interest. The gene discussed is CLEC7A; the disease is cancer.